Viking Therapeutics Inc. (VKTX)
Why Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?
Viking Therapeutics (VKTX) reported earnings 30 days ago. What's next for the stock?
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $32.18, denoting a +1.64% move from the preceding trading day.
Viking Therapeutics: Market Betting On Big Upside Through 2030
Viking Therapeutics is making really solid pipeline progress and possesses a unique dual agonist approach in the fast-growing obesity drugs market. VKTX targets a 5–10% market share, leveraging global expansion and late-stage development to compete with incumbents Lilly and Novo Nordisk. Nothing is over just yet. Phase 3 for VK2735 Oral is set for late 2026, with initial commercial ramp expected in 2028 and potential $1.3B sales by 2030. A hockey stick inflection could pan out.
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
Buy the story, sell the news. That's a reasonable explanation for why Viking Therapeutics NASDAQ: VKTX fell over 3% the day the company delivered its Q1 2026 earnings report.
VKTX Q1 Earnings Miss on Higher Phase 3 Development Costs
Viking Therapeutics posts a wider Q1 loss as R&D spend jumps on Phase III obesity drug work, while it advances VK2735 studies and preps oral late-stage study.
Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call Transcript
Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call Transcript
Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights
Viking Therapeutics, Inc. (VKTX) closed at $32.8 in the latest trading session, marking a -4.23% move from the prior day.
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
Viking Therapeutics, Inc. (VKTX) reached $35.52 at the closing of the latest trading day, reflecting a +1.46% change compared to its last close.
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing
Viking Therapeutics, Inc. (VKTX) concluded the recent trading session at $35.01, signifying a +2.19% move from its prior day's close.
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $33.93, representing a -2.5% change from its previous close.
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors
In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.94, indicating a -7.95% shift from the previous trading day.
